Schedule 13G ownership disclosure
UROGEN PHARMA LTD
Ordinary Shares, par value NIS 0.01 per share · CUSIP: M96088105
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Adage Capital Management, L.P.
Shares: 2,928,086.00 · Class: 6.94%
- Robert Atchinson
Shares: 2,928,086.00 · Class: 6.94%
- Phillip Gross
Shares: 2,928,086.00 · Class: 6.94%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-000866
- Form type
- SCHEDULE 13G/A
- Filer
- Adage Capital Management, L.P.
- CIK
- CIK 1535978
- Filed
- Feb 12, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership